Health TrialsbyHealthPanel

Improving Pancreatic Cancer Care by the Use of Computational Science and Technology

ConditionsPancreatic CancerPancreatic CystPancreatic AdenocarcinomaPancreatic DiseasesPancreas AdenocarcinomaPancreas Cyst
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUMC Utrecht

About this trial

The goal of the IMPACT project is to set up a data sharing infrastructure between expert centers for pancreatic surgery that enables training, testing and validation of computer science tools to improve quality of care for patients with pancreatic cancer.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

≥18 years of age

Patients who received diagnostic procedures and/or treatment for (suspected) benign and malignant pancreatic lesions as registered in the Dutch Pancreatic Cancer Project (PACAP) audit database and healthy individuals who received an abdominal CT-scan (controls)

Disqualifiers

None

Trial population

All patients who underwent diagnostic procedures and/or treatment for (suspected) benign and malignant pancreatic lesions as registered in the Dutch Pancreatic Cancer Project (PACAP) audit database, as well as healthy individuals who received an abdominal CT-scan (controls).

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • No interventions

    Other intervention

    Considering the retrospective nature of this project and use of existing clinical and technical data, this project contains no interventions or prospective inclusion of healthy subjects / patients for the execution of experiments.

Treatment groups

5,000 Participants
are divided into 2 treatment groups
Group A: Healthy individuals1 intervention
Group B: Individuals with pancreatic lesions1 intervention

Trial outcomes

Primary outcomes

1

Subproject dependent

Endpoints within this project are dependent on the specific subprojects. This study will facilitate the collection of large amounts of real-world data for (future) computer science projects.

Time frame
Through study completion, an average of 5 years.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

UMC Utrecht

Lead sponsor

Catharina Ziekenhuis Eindhoven

Collaborator

St. Antonius Hospital

Collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborator

University Medical Center Groningen

Collaborator

Medisch Spectrum Twente

Collaborator

Erasmus Medical Center

Collaborator

Maastricht University Medical Center

Collaborator

Leiden University Medical Center

Collaborator

NYU Langone Health

Collaborator

Johns Hopkins University

Collaborator

Delft University of Technology

Collaborator

Source ClinicalTrials.gov
Apply now